SK

Sanjay Kumar Mohta

Active Director Designated Partner DIN 07089040
DIN 07089040 First appointment Jul 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjay Kumar Mohta

Data last updated:

Sanjay Kumar Mohta is a Designated Partner at Nu Sri Shyam Healthcare Llp (since 2021). The company operates in Pharma.

DIN 07089040
Primary Designation Designated Partner
Industry Pharma
First Appointment 26 Jul 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner26 Jul 20212021Active

Board colleagues of Sanjay Kumar Mohta

Directorship timeline

Open interactive timeline →
Nu Sri Shyam Healthcare Llp
Premium access

Shareholding and investment profile for Sanjay Kumar Mohta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Kumar Mohta

Sanjay Kumar Mohta currently holds 1 directorship: Nu Sri Shyam Healthcare Llp (Designated Partner, since 26 Jul 2021).

Sanjay Kumar Mohta was first appointed on 26 Jul 2021 as Designated Partner at Nu Sri Shyam Healthcare Llp.

The current boards of Sanjay Kumar Mohta's companies include Aniruddha Kaushal (Nu Sri Shyam Healthcare Llp), Nishant Chokhani (Nu Sri Shyam Healthcare Llp), Tarun Kaushal (Nu Sri Shyam Healthcare Llp), Varun Chokhani (Nu Sri Shyam Healthcare Llp), Vineet Kothari (Nu Sri Shyam Healthcare Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available